Page last updated: 2024-12-05

luminol

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

Luminol is a chemical compound that exhibits chemiluminescence, emitting a bright blue light when mixed with an appropriate oxidizing agent. It is synthesized through a multi-step process that involves the reaction of 3-nitrophthalic hydrazide with sodium hypochlorite. Luminol's luminescence is enhanced in the presence of a catalyst, often a heavy metal ion such as iron or copper. Its ability to react with bloodstains has made luminol a valuable tool in forensic science for detecting traces of blood at crime scenes. The oxidation of luminol by hydrogen peroxide in the presence of a catalyst produces an excited state of the luminol molecule, which emits light as it returns to its ground state. The blue light emitted by luminol is particularly useful in dark environments. Furthermore, luminol is used in analytical chemistry for detecting trace amounts of various substances, including transition metals and other compounds that can catalyze its oxidation. Luminol research continues to explore its applications in diverse fields, such as biosensing, environmental monitoring, and medical diagnostics. This compound's unique chemiluminescent properties have prompted ongoing investigations into its potential use in various detection methods and analytical techniques.'

Luminol: 5-Amino-2,3-dihydro-1,4-phthalazinedione. Substance that emits light on oxidation. It is used in chemical determinations. [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID10638
CHEMBL ID442329
SCHEMBL ID20086
MeSH IDM0012737

Synonyms (88)

Synonym
EU-0066798
5-amino-2,3-dihydro-1,4-phthalazinedone
AC-13306
unii-5exp385q4f
5exp385q4f ,
EN300-16893
BB 0245795
nsc5064
3-aminophthalic hydrazide
nsc-5064
3-aminophthalhydrazide
1, 3-amino-, cyclic hydrazide
1, 5-amino-2,3-dihydro-
mls002637790 ,
luminol
3-aminophthalic acid hydrazide
521-31-3
1,4-phthalazinedione, 5-amino-2,3-dihydro-
SDCCGMLS-0065581.P001
5-amino-2,3-dihydrophthalazine-1,4-dione
OPREA1_819727
OPREA1_698774
NCGC00091452-01
inchi=1/c8h7n3o2/c9-5-3-1-2-4-6(5)8(13)11-10-7(4)12/h1-3h,9h2,(h,10,12)(h,11,13
5-amino-1,2,3,4-tetrahydrophthalazine-1,4-dione
nsc 5064
ccris 5962
3-aminophthalylhydrazide
1,2-benzenedicarboxylic acid, 3-amino-, cyclic hydrazide
ai3-52555
einecs 208-309-4
luminol, >=97% (hplc)
luminol, 97%
5-amino-2,3-dihydro-1,4-phthalazinedione
5-aminophthalazine-1,4-diol
STK138069
L-8610
L-8600
3-aminophthaloylhydrazine
smr001547307
AKOS000111313
5-amino-2,3-dihydro-phthalazine-1,4-dione
bdbm50125759
AKOS002945870
CHEMBL442329 ,
NCGC00091452-02
BBL002758
o-aminophthalylhydrazide
HMS3093K04
dtxsid5024504 ,
NCGC00258494-01
cas-521-31-3
tox21_200940
dtxcid004504
(e)-4-oxo-4-(3-triethoxysilylpropylamino)but-2-enoic acid;luminol
20666-12-0
A814795
5-amino-2,3-dihydrophthalazine-1,4-dione;luminol sodium salt
A828942
o-aminophthaloyl hydrazide
STL280212
5-amino-1,2,3,4-tetrahydro-1,4-phthalazinedione
3-aminophthalhydrazine
5-amino-4-hydroxyphthalazin-1(2h)-one
FT-0615056
S6819
HY-15922
AKOS016399881
SCHEMBL20086
luminol [mi]
5-amino-1,4-dihydroxyphthalazine
STR04818
L-8601
AC-33248
mfcd00006890
F1313-0002
SR-01000389300-1
sr-01000389300
Z56813244
luminol, for chemiluminescence, >=98.0% (hplc)
luminol, saj special grade
5-amino-1,4-phthalazinediol
SY011102
BCP18652
Q408061
HB0796
1h-1,2,4-triazole,3-iodo-
monosodium-alpha-luminol

Research Excerpts

Overview

Luminol is a prominent chemiluminescent (CL) agent, finding applications across numerous fields, including forensics, immunoassays, and imaging. It is a non-radical-specific amplifying molecule which produces light upon interaction with various reactive oxygen intermediates.

ExcerptReferenceRelevance
"Luminol is a classic electrochemiluminescence (ECL) luminophore. "( High-Intensity Focused Ultrasound Combined with Ti
Wang, Z; Wei, Z; Zhang, H, 2023
)
2.35
"Luminol is a major probe for chemiluminescence (CL) and electrochemiluminescence (ECL) detection technologies in (bio)analysis. "( Shedding Light on the Diversity of Surfactant Interactions with Luminol Electrochemiluminescence for Bioanalysis.
Baeumner, AJ; Duerkop, A; Gerstl, F; Hahn, M; Köwer, T; Kunz, W; Mayer, M; Rink, S, 2019
)
2.2
"Luminol is a popular molecule that is currently gaining further interest due to its potential role for non-invasive cancer treatments. "( On the chemiluminescence emission of luminol: protic and aprotic solvents and encapsulation to improve the properties in aqueous solution.
Borrego-Sánchez, A; Giussani, A; Roca-Sanjuán, D; Rubio, M, 2020
)
2.27
"Luminol is a prominent chemiluminescent (CL) agent, finding applications across numerous fields, including forensics, immunoassays, and imaging. "( Building a Functionalizable, Potent Chemiluminescent Agent: A Rational Design Study on 6,8-Substituted Luminol Derivatives.
Cuquerella, MC; Giussani, A; Mikroulis, T; Miranda, MA; Pantelia, A; Roca-Sanjuán, D; Rodríguez-Muñiz, GM; Rotas, G; Vougioukalakis, GC, 2021
)
2.28
"Luminol is a reagent that is used to enhance areas of non-visible bloodstaining and it is one of the most sensitive of such reagents available to the forensic scientist. "( Illuminating the health and safety of luminol.
Gannicliffe, C; Larkin, T, 2008
)
2.06
"Luminol is a presumptive test reagent used for the location of latent bloodstains. "( An evaluation of luminol formulations and their effect on DNA profiling.
Hopwood, A; Patel, G, 2013
)
2.17
"Luminol is a non-radical-specific amplifying molecule which produces light upon interaction with various reactive oxygen intermediates (ROIs). "( Luminol-dependent chemiluminescence is related to the extracellularly released reactive oxygen intermediates in the case of rat neutrophils activated by formyl-methionyl-leucyl-phenylalanine.
Csikor, K; Fûrész, J; Lakatos, S; Németh, K; Schweitzer, K, 2002
)
3.2
"Luminol itself is a xanthine oxidase inhibitor and its concentration affects the reaction mechanism."( Variables in xanthine oxidase-initiated luminol chemiluminescence: implications for chemiluminescence measurements in biological systems.
Vilím, V; Wilhelm, J, 1986
)
1.26

Effects

Luminol has been reported to detect myeloperoxidase (MPO) activity in an inflamed area through a light-emitting reaction. It is easy to use and does not pose any health risks, while providing trace evidence for DNA analysis.

ExcerptReferenceRelevance
"The luminol test has been used for over 60 years by forensic investigators for presumptive identification of blood and visualization of blood splatter patterns. "( A quantitative method for determining a representative detection limit of the forensic luminol test for latent bloodstains.
Abraham, AM; Belliveau, EO; Cassidy, BM; DeJong, SA; Ervin, SM; Kellogg, KW; Kilgore, KE; Lu, Z; Martin, JP; Meece-Rayle, M; Morgan, SL; Myrick, ML; Tazik, SK, 2017
)
1.24
"Luminol has been reported to detect myeloperoxidase (MPO) activity in an inflamed area through a light-emitting reaction."( Bioluminescence Imaging of Inflammation in Vivo Based on Bioluminescence and Fluorescence Resonance Energy Transfer Using Nanobubble Ultrasound Contrast Agent.
Dai, Z; Liu, R; Tang, J; Xu, Y, 2019
)
1.24
"Luminol has been used for a long time for detecting latent blood traces during police investigations because it is easy to use and does not pose any health risks, while providing trace evidence for DNA analysis. "( Blood Trace Evidence on Washed Textiles - a systematic approach.
Augustin, C; Edler, C; Gehl, A; Klein, A; Kohwagner, J; Krebs, O; Walther, M, 2017
)
1.9

Actions

ExcerptReferenceRelevance
"Luminol may produce a peak in chemiluminescence by stimulating very low levels of hexose monophosphate shunt activity and superoxide generation or it may simply amplify light production generated by the production of excited oxygen radicals resulting from surface interactions."( Luminol-induced neutrophil chemiluminescence.
Allred, CD; Hill, HR; Margetts, J, 1980
)
2.43

Toxicity

ExcerptReferenceRelevance
" Cerebellar granule cells at 12 days in culture when treated with a toxic dose of glutamate (100 microM) showed a rapid and transient increase of polyADP-ribose immunoreactivity."( Poly(ADP-ribose) polymerase: early involvement in glutamate-induced neurotoxicity in cultured cerebellar granule cells.
Cosi, C; Facci, L; Kanai, Y; Menegazzi, M; Milani, D; Skaper, SD; Suzuki, H; Vantini, G, 1994
)
0.29
" We have recently observed that Abetas exert a toxic effect on neuromicrovascular endothelial cells (NECs) in a time- and concentration-dependent manner, apoptosis playing a pivotal role in this process."( Caspase-8 activation and oxidative stress are involved in the cytotoxic effect of beta-amyloid on rat brain microvascular endothelial cells.
Baiguera, S; Conconi, MT; Fioravanzo, L; Folin, M; Grandi, C; Nussdorfer, GG; Parnigotto, PP, 2006
)
0.33

Pharmacokinetics

ExcerptReferenceRelevance
" The pharmacokinetic parameters including absorption rate constant (0."( Human saliva-based quantitative monitoring of clarithromycin by flow injection chemiluminescence analysis: a pharmacokinetic study.
Song, Z; Tan, X, 2014
)
0.4

Compound-Compound Interactions

ExcerptReferenceRelevance
"An electrochemiluminescence (ECL) inhibition method combined with molecularly imprinted solid phase extraction (MISPE) was developed for quantitative determination of malachite green (MG) residues in fish."( Determination of malachite green residues in fish using a highly sensitive electrochemiluminescence method combined with molecularly imprinted solid phase extraction.
Duan, J; Gai, P; Guo, Z; Hao, T; Wang, S, 2011
)
0.37

Bioavailability

ExcerptReferenceRelevance
" Physical stressors included thermogenic microwave radiation (2,450 MHz, mean specific absorption rate of 91 W/kg) and conventional heating with hot air or hot-water bath."( Physiologic aging of mature porcine erythrocytes: effects of various metabolites, antimetabolites, and physical stressors.
Erwin, DN; Kiel, JL, 1986
)
0.27
"Sheep red blood cells (SRBCs) were labelled with a concanavalin A-luminol-bovine serum albumin conjugate specific for the transmembrane anion transport protein (Band 3) and exposed to 2450 MHz continuous wave microwave radiation at an average specific absorption rate of 91 W/kg for 10 min."( Microwave radiation effects on the thermally driven oxidase of erythrocytes.
Erwin, DN; Kiel, JL,
)
0.37
" However, it has had problems in the production of TCL materials and in conversion of the luminescent signal into specific absorption rate (SAR)."( Luminescent radio frequency radiation dosimetry.
Alls, JL; Erwin, DN; Kiel, JL; Mason, PA, 1999
)
0.3
" Thus to further improve the NAC bioavailability a single oral administration of 1200 mg NAC has been recently proposed."( Human neutrophil oxidative bursts and their in vitro modulation by different N-acetylcysteine concentrations.
Allegra, L; Bovio, C; Braga, PC; Dal Sasso, M; Fonti, E; Massoni, C, 2002
)
0.31
"Considering that antioxidant flavonols have been reported to be beneficial to human health, but that their low water solubility and bioavailability limit their administration through systemic route, the development of suitable flavonol-carriers is of great importance for clinical therapeutics."( In vitro evaluation of the antioxidant activity of liposomal flavonols by the HRP-H2O2-luminol system.
Azzolini, AE; Bentley, MV; de Oliveira, CA; Del Ciampo, JO; Kabeya, LM; Landi-Librandi, AP; Lucisano-Valim, YM, 2011
)
0.59
" The pharmacokinetic parameters including absorption rate constant (0."( Human saliva-based quantitative monitoring of clarithromycin by flow injection chemiluminescence analysis: a pharmacokinetic study.
Song, Z; Tan, X, 2014
)
0.4

Dosage Studied

ExcerptRelevanceReference
" Comparison of PMN and macrophages from different species showed that the maximal chemiluminescent response seen in the dose-response curve of F-Met- Phe was different in different cell types."( Chemiluminescence of phagocytic cells caused by N-formylmethionyl peptides.
Gardner, DE; Hatch, GE; Menzel, DB, 1978
)
0.26
" Pretreatment of polymorphonuclear granulocytes (PNG) with cefpodoxime at therapeutical dosage in vitro did not have a significant effect on chemotaxis and luminol-dependent chemiluminescence."( Influence of cefpodoxime on selected immunological functions and bacterial pathogenicity factors in vitro.
Schubert, S; Ullmann, U, 1991
)
0.48
"The dose-response relationship of four commercially available barbiturates (methohexitone, pentobarbitone, phenobarbitone and thiopentone) and of their drug-free solutions on the production of oxygen radicals by neutrophils were tested by N-formylmethionyl-leucyl-phenylalanine (FMLP)-induced granulocyte chemiluminescence and in a cell-free chemiluminescence system."( Do barbiturates and their solutions suppress FMLP-induced neutrophil chemiluminescence?
Birkhahn, A; Buhl, R; Mirow, N; Schneider, M; Weiss, M; Wernet, P, 1994
)
0.29
" Male Fischer 344 rats were dosed intratracheally with silica (2."( Characteristics of the acute-phase pulmonary response to silica in rats.
Antonini, JM; DiMatteo, M; Reasor, MJ; Van Dyke, K, 1996
)
0.29
" Acetaminophen is a phenolic compound which produces a clear inhibitory dose-response curve with peroxynitrite in its range of clinical effectiveness."( A new screening method to detect water-soluble antioxidants: acetaminophen (Tylenol) and other phenols react as antioxidants and destroy peroxynitrite-based luminol-dependent chemiluminescence.
Qazi, N; Sacks, M; Van Dyke, K,
)
0.33
" But the use of the preparation in the pellet form gave some additional advantage: simplicity of use, painlessness, dosage accuracy and possibility not to attend doctor."( [Study of local immunostimulating effect of the use of different pharmaceutical forms of the remedy Traumeel S in treatment of inflammatory parodontal diseases].
Aleksandrovskaia, IIu; Bezrukova, IV; Grudianov, AI; Serebriakova, LE, 2006
)
0.33
" The proposed method was employed for the determination of CTP in bulk drug, in its pharmaceutical dosage forms and biological fluids such as human serum and urine."( Application of silver nanoparticles to the chemiluminescence determination of cefditoren pivoxil using the luminol-ferricyanide system.
Alarfaj, NA; Aly, FA; El-Tohamy, MF, 2015
)
0.63
" It responded to the dosage of anti-MA in spiked blood samples with satisfactory recovery."( A Convenient Electrochemiluminescent Immunosensor for Detecting Methamphetamine Antibody.
Liu, C; Tu, Y; Wang, X; Yang, Y; Zhai, S, 2019
)
0.51
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Protein Targets (18)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
thioredoxin reductaseRattus norvegicus (Norway rat)Potency44.66840.100020.879379.4328AID588456
TDP1 proteinHomo sapiens (human)Potency15.27550.000811.382244.6684AID686978; AID686979
AR proteinHomo sapiens (human)Potency1.71690.000221.22318,912.5098AID1259243; AID1259381
aldehyde dehydrogenase 1 family, member A1Homo sapiens (human)Potency35.48130.011212.4002100.0000AID1030
estrogen receptor 2 (ER beta)Homo sapiens (human)Potency13.75500.000657.913322,387.1992AID1259377
retinoic acid nuclear receptor alpha variant 1Homo sapiens (human)Potency49.86610.003041.611522,387.1992AID1159552; AID1159555
retinoid X nuclear receptor alphaHomo sapiens (human)Potency5.52300.000817.505159.3239AID1159527
estrogen-related nuclear receptor alphaHomo sapiens (human)Potency56.99730.001530.607315,848.9004AID1224841; AID1224842; AID1224848; AID1224849
estrogen nuclear receptor alphaHomo sapiens (human)Potency18.75960.000229.305416,493.5996AID743069; AID743075; AID743078
Histone H2A.xCricetulus griseus (Chinese hamster)Potency28.54120.039147.5451146.8240AID1224845
tumor necrosis factorHomo sapiens (human)Potency59.55720.375823.492842.1632AID651757
importin subunit beta-1 isoform 1Homo sapiens (human)Potency5.80485.804836.130665.1308AID540253
snurportin-1Homo sapiens (human)Potency5.80485.804836.130665.1308AID540253
nuclear factor erythroid 2-related factor 2 isoform 1Homo sapiens (human)Potency74.97800.000627.21521,122.0200AID651741
GTP-binding nuclear protein Ran isoform 1Homo sapiens (human)Potency5.80485.804816.996225.9290AID540253
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Queuine tRNA-ribosyltransferaseZymomonas mobilis subsp. mobilis ZM4 = ATCC 31821Ki36.00000.60004.45008.3000AID228037
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (12)

Assay IDTitleYearJournalArticle
AID588499High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set2010Current protocols in cytometry, Oct, Volume: Chapter 13Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening.
AID588499High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set2006Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5
Microsphere-based protease assays and screening application for lethal factor and factor Xa.
AID588499High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set2010Assay and drug development technologies, Feb, Volume: 8, Issue:1
High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors.
AID1745845Primary qHTS for Inhibitors of ATXN expression
AID588501High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set2010Current protocols in cytometry, Oct, Volume: Chapter 13Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening.
AID588501High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set2006Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5
Microsphere-based protease assays and screening application for lethal factor and factor Xa.
AID588501High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set2010Assay and drug development technologies, Feb, Volume: 8, Issue:1
High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors.
AID588497High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set2010Current protocols in cytometry, Oct, Volume: Chapter 13Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening.
AID588497High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set2006Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5
Microsphere-based protease assays and screening application for lethal factor and factor Xa.
AID588497High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set2010Assay and drug development technologies, Feb, Volume: 8, Issue:1
High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors.
AID651635Viability Counterscreen for Primary qHTS for Inhibitors of ATXN expression
AID228037Inhibitory activity against eubacterial tRNA guanine transglycosylase (TGT) from Zymomonas mobilis2003Journal of medicinal chemistry, Mar-27, Volume: 46, Issue:7
Virtual screening for submicromolar leads of tRNA-guanine transglycosylase based on a new unexpected binding mode detected by crystal structure analysis.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (2,125)

TimeframeStudies, This Drug (%)All Drugs %
pre-1990398 (18.73)18.7374
1990's518 (24.38)18.2507
2000's418 (19.67)29.6817
2010's585 (27.53)24.3611
2020's206 (9.69)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 82.92

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be very strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index82.92 (24.57)
Research Supply Index7.83 (2.92)
Research Growth Index4.69 (4.65)
Search Engine Demand Index151.63 (26.88)
Search Engine Supply Index2.01 (0.95)

This Compound (82.92)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials27 (1.09%)5.53%
Reviews57 (2.30%)6.00%
Case Studies6 (0.24%)4.05%
Observational1 (0.04%)0.25%
Other2,386 (96.33%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]